Table 3.
Drug | Mechanism | Reference |
---|---|---|
Chloroquine | Induces mitochondrial damage, results in mitochondrial membrane depolarization and the release of cytochrome c; inhibits cytochrome c oxidase activity, thus increases the ROS level |
[83] |
Niclosamide | Disturbs mitochondrial respiration and induces mitochondrial depolarization, thus promotes glycolysis and decreases glycolytic capacity and reserve | [86] |
Upregulates pyruvate influx into mitochondria and lowers the pentose phosphate pathway and phosphoglycerate activity dehydrogenase pathway | [87] | |
Triggers intracellular calcium flux via mitochondrial uncoupling, thus disturbs the arachidonic acid metabolism in a p53 deficit-dependent manner | [88] | |
Induces apoptosis via the intrinsic mitochondrial pathway | [89] | |
Ivermectin | Induces mitochondrial dysfunction and oxidative stress via inhibiting the Akt/mTOR pathway | [90] |
Induces mitochondrial damage leads to increased Bax/Bcl-2 ratio, which leads to cytoplasm c release and caspase-mediated cancer cell apoptosis | [93] | |
Nitazoxanide/RM4819 | Both NTZ and RM4819 exhibit mitochondria uncoupling effect, only RM4819 shows mitochondria complex III inhibitory effect | [94,95] |